GW Pharmaceuticals GWPH 2017 Corporate Presentation

GW Pharmaceuticals plc filed a Form 6-K in March 2017 containing results of its annual general shareholder meeting and an updated corporate presentation. The company is a biopharmaceutical firm focused on cannabinoid-based medicines for therapeutic use.